SU2C and Raise Money For Cancer Research

On Friday, September 7 at 8 pm ET, celebrities and musicians will come together to build awareness for cancer and raise money for cancer research through the Stand Up 2 Cancer (SU2C) telethon.

100 percent of all public donations from the special will go to cancer research.

 

 

Watch the Stand Up 2 Cancer Special

The Stand Up 2 Cancer Special airs Friday, September 7 from 8 to 9 pm ET.

Stand Up 2 Cancer will air on all major networks without commercial interruption. Networks include ABC, NBC, CBS as well as BIO, E!, HBO, MLB Network, Palladia, Showtime TBS, VH1 and STARZ.

About Stand Up 2 Cancer

Founded in 2008, SU2C has raised more than $180 million for innovative cancer research. Since its inception, SU2C has made grants to seven multi-disciplinary “Dream Teams” of researchers as well as to 26 young innovative scientists who are undertaking potentially high-reward projects to end the reign of cancer as a leading cause of death in the world today.

Eighty-five institutions are currently involved, including Penn Medicine’s Abramson Cancer Center.

The Penn Medicine SU2C Dream Team

As the fourth leading cause of cancer death in the United States, pancreatic cancer remains one of the most deadly forms of cancer. More than 90 percent of patients die within the first year of diagnosis. Recent advancements have had little impact, and a new approach is desperately needed.

The SU2C Dream Team at Penn is actively researching better ways to prevent, diagnose and treat pancreatic cancer. Together, members of the Pancreatic Cancer Dream Team working to translate scientific breakthroughs into new treatment options faster than ever before. Their research focuses on developing tests using advanced imaging technology to understand pancreatic cancer cells and developing new, personalized pancreatic cancer treatments based on their research.

Members of the Pancreatic Cancer SU2C Dream Team at Penn Medicine

Pancreatic cancer researchers at Penn Medicine are at the forefront of developing new, personalized approaches to pancreatic cancer treatment.

These Penn clinicians and researchers are part of the SU2C Pancreatic Cancer Dream Team.

Chi Van Dang, MD, PhD
Professor of Medicine, Hematology/Oncology
Director, Abramson Cancer Center
Director, Abramson Family Cancer Research Institute

Jeffrey A. Drebin, MD, PhD, FACS
John Rhea Barton Professor of Surgery
Chairman, Department of Surgery

Hank Kung, PhD
Professor of Radiology and Pharmacology
Department of Radiology
Perelman School of Medicine

Peter J. O’Dwyer, MBBCh, MD
Professor of Medicine, Hematology/Oncology
Perelman School of Medicine

Watch Stand Up 2 Cancer and Join the Conversation

Watch Stand Up 2 Cancer Friday, September 7 at 8 pm ET.